SCHEMBL30848066

SCHEMBL30848066

Cn1ncc2ccc(OC3CC3)c(NS(=O)(=O)c3cnn(-c4ccnc(C(F)(F)F)c4)c3)c21

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 2/20 0.34
▸ GRIN1 Q05586 2/20 0.34
▸ GRIN2B Q13224 2/20 0.34
▸ SCN9A Q15858 5/20 0.33
▸ AXL P30530 3/20 0.33
▸ TYRO3 Q06418 3/20 0.33
▸ MERTK Q12866 2/20 0.33
▸ ACACB O00763 2/20 0.33
▸ SCN1A P35498 2/20 0.32
▸ SCN8A Q9UQD0 2/20 0.32
▸ CHRM4 P08173 1/20 0.32
▸ PDE4B Q07343 1/20 0.32
▸ PDE4D Q08499 1/20 0.32
▸ UGCG Q16739 1/20 0.32
▸ GPR6 P46095 1/20 0.32
▸ KCNH2 Q12809 1/20 0.31
▸ LRRK2 Q5S007 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27132716 1.00 RXRA (0.34) RXRAGRIN1GRIN2BSCN9AAXL
SCHEMBL27132406 0.89 RXRA (0.37) RXRAGRIN1GRIN2BSCN9A
SCHEMBL30847861 0.89 RXRA (0.37) RXRAGRIN1GRIN2BSCN9A
SCHEMBL30847993 0.89 SLC40A1 (0.38) RXRAGRIN1GRIN2BSCN9A
SCHEMBL27132348 0.89 SLC40A1 (0.38) RXRAGRIN1GRIN2BSCN9A
SCHEMBL30848028 0.87 SCN9A (0.34) RXRAGRIN1GRIN2BSCN9ALRRK2
SCHEMBL27132407 0.87 SCN9A (0.34) RXRAGRIN1GRIN2BSCN9ALRRK2
SCHEMBL27132783 0.86 RXRA (0.36) RXRAGRIN1GRIN2BSCN9ACHRM4
SCHEMBL30848042 0.86 RXRA (0.36) RXRAGRIN1GRIN2BSCN9ACHRM4
SCHEMBL30847936 0.86 CYP17A1 (0.38) RXRAGRIN1GRIN2BSCN9ACHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577536-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY Hotspot Therapeutics, Inc. (US) 2025-07-02 — — EP disclosed
WO-2024044730-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback